Creative Planning
FRTX

Creative Planning’s Fresh Tracks Therapeutics, Inc. Common Stock FRTX Stock Holding History

Creative Planning’s Portfolio FRTX Stock Details FRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-77
Closed -$35K – 2196
2018
Q1 		$35K Buy
+77
New +$38.2K ﹤0.01% 1851
2017
Q3 		– Hold
0
– – – 3903
2017
Q2 		– Hold
0
– – – 4892
2017
Q1 		– Hold
0
– – – 4969
2016
Q4 		– Hold
0
– – – 4905
2016
Q3 		– Hold
0
– – – 4782
2016
Q2 		– Hold
0
– – – 4570

Other funds holding FRTX

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $26.7B AUM 36.4% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Creative Planning's FRTX Position: Q2 2018 in Review

Creative Planning sold out of Fresh Tracks Therapeutics, Inc. Common Stock (FRTX) in Q2 2018, closing a stake of 77 shares — an estimated $35K sold.

Creative Planning first reported a position in FRTX in Q1 2018 and held it in 1 quarter. The position peaked at $35K in Q1 2018. 28 funds tracked by Wall St. Rank hold FRTX as of Q2 2018.

  • Creative Planning reported no remaining Fresh Tracks Therapeutics, Inc. Common Stock position as of Q2 2018 after selling out during the quarter.
  • Creative Planning sold 77 Fresh Tracks Therapeutics, Inc. Common Stock shares in Q2 2018, an estimated $35K.
  • Creative Planning first reported a position in Fresh Tracks Therapeutics, Inc. Common Stock in Q1 2018 and held it in 1 quarter.
  • Creative Planning's Fresh Tracks Therapeutics, Inc. Common Stock position peaked at $35K in Q1 2018.
  • 28 funds tracked by Wall St. Rank held Fresh Tracks Therapeutics, Inc. Common Stock as of Q2 2018.

Based on Creative Planning's 13F filing for Q2 2018, filed 20 Jul 2018.